Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

UCLA1, a synthetic derivative of a gp120 RNA aptamer, inhibits entry of human immunodeficiency virus type 1 subtype C.

Mufhandu HT, Gray ES, Madiga MC, Tumba N, Alexandre KB, Khoza T, Wibmer CK, Moore PL, Morris L, Khati M.

J Virol. 2012 May;86(9):4989-99. doi: 10.1128/JVI.06893-11. Epub 2012 Feb 29.

2.

The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection.

Gray ES, Madiga MC, Hermanus T, Moore PL, Wibmer CK, Tumba NL, Werner L, Mlisana K, Sibeko S, Williamson C, Abdool Karim SS, Morris L; CAPRISA002 Study Team.

J Virol. 2011 May;85(10):4828-40. doi: 10.1128/JVI.00198-11. Epub 2011 Mar 9.

3.

Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region.

Gray ES, Madiga MC, Moore PL, Mlisana K, Abdool Karim SS, Binley JM, Shaw GM, Mascola JR, Morris L.

J Virol. 2009 Nov;83(21):11265-74. doi: 10.1128/JVI.01359-09. Epub 2009 Aug 19.

4.

Dichloromethane extract of Dicerocaryum senecioides leaves exhibits remarkable anti-inflammatory activity in human T-lymphocytes.

Madiga MC, Cockeran R, Mokgotho MP, Anderson R, Mampuru LJ.

Nat Prod Res. 2009;23(11):998-1006. doi: 10.1080/14786410802394140.

PMID:
19521914

Supplemental Content

Loading ...
Support Center